Medication knowledge and beliefs in patients with major depressive disorder at a tertiary health facility in north east Nigeria

Yusuf, Hadiza; Ohieku, JD; Haruna, Wazis C; Bello, FA; Abdu-Aguye, Samirah N

doi:10.4314/njpr.v15i2.2

Cited by 4 publications

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Little is known about outpatient medication knowledge and satisfaction with medication counselling within the Nigerian setting [22,23], thus the need for further research on these topics. Furthermore, because medication knowledge and satisfaction with counselling are linked to the optimal use of medication by patients, assessing these variables are important steps in evaluating the quality of services provided and identifying areas for improvement.…”

Section: Introductionmentioning

confidence: 99%

An exploratory study of outpatient medication knowledge and satisfaction with medication counselling at selected hospital pharmacies in Northwestern Nigeria

et al. 2022

View full text Add to dashboard Cite

Background Medication counselling is an important activity that improves patient therapeutic outcomes. After this activity has been carried out, patients should be satisfied with counselling, and possess adequate knowledge about their medications. Objectives To describe outpatient/caregiver medication knowledge and satisfaction with medication counselling at the main outpatient pharmacies of eight public secondary and tertiary hospitals located in two states in Northwestern Nigeria. Methods Exit interviews were conducted from December 2019 to March 2020 with randomly sampled patients/caregivers who had just been dispensed one or more prescription medications from the main pharmacies of the hospitals. The questionnaire used contained 31 questions in three sections. The first section collected demographic information. The second section assessed respondents’ experiences and overall satisfaction with the counselling they had received. The last section evaluated respondents’ knowledge of one randomly selected prescription medication that had been dispensed to them. Data collected were coded and analyzed to generate descriptive statistics. To explore associations between respondent characteristics and overall satisfaction, non-parametric tests were used, and statistical significance set at p<0.05. Results A total of 684 patients/caregivers were interviewed. Majority of respondents agreed that the time spent (97.1%) and quantity of information (99.1%) provided during counselling was adequate. However, over 60% of them also agreed that dispensers did not assess their understanding of information provided or invite them to ask questions. Despite this, their average overall satisfaction with counselling on a 10-point scale was 8.6 ± 1.6. Over 90% of them also correctly identified the routes and frequency of administration of the prescribed medication selected for the knowledge assessment. Although, more than 60% of respondents did not know the duration of therapy or names of these medications. Conclusion Respondents’ satisfaction with medication counselling was fairly high even though they did not seem to know much about their medication.

show abstract

Section: Introductionmentioning

confidence: 99%

An exploratory study of outpatient medication knowledge and satisfaction with medication counselling at selected hospital pharmacies in Northwestern Nigeria

et al. 2022

View full text Add to dashboard Cite

show abstract

“…The variety of medical treatments available, the frequent occurrence of side effects from drug treatment, and associated low medication compliance are all challenges that care providers face when managing schizophrenia. As a result, pharmacists play several critical roles in the overall successful treatment of schizophrenia patients [7]. While psychosocial and psychotherapeutic interventions are important for improving outcomes, antipsychotic drug treatment is the cornerstone of schizophrenic psychosis management.…”

Section: Introductionmentioning

confidence: 99%

The Role of Clinical Pharmacists as a Collaborative Team for Ambulatory Care in Schizophrenic Patients

Harjaningsih¹

2023

New Community Health Models [Working Title]

View full text Add to dashboard Cite

Schizophrenia is a severe and chronic mental illness that affects more than 21 million people worldwide of the population with significant impact on the quality of life of those who suffer from it. Because the disorder is multifaceted, treatment should address all aspects of it. Efforts to improve outcomes for people with mental illnesses frequently include incorporating the skills of various health professionals into collaborative care models. In schizophrenia outpatients, clinical pharmacy plays a critical role in ambulatory care. Pharmacists increased patient interest in health counseling regarding behavior during counseling and even initiated direct patient counseling or referrals. In conclusion, the role of clinical pharmacist in schizophrenia outpatients is as follows: educate patients and their families; maintain medication compliance in patients; create a collaborative teamwork environment and keep track of drug side effects. Family support is required in Indonesia to help schizophrenic patients recover, and education about how to stop shackling for family members with schizophrenia is critical. Given the negative stigma attached to patients and the prevalent culture of shackling, the role of pharmacists in collaborative teams with other health workers is critical in Indonesia in the future.

show abstract

Impact of pharmacist intervention on antidepressant medication adherence and disease severity in patients with major depressive disorder in fragile north-east Nigeria

Yusuf

Magaji

Maiha

et al. 2021

Journal of Pharmaceutical Health Services Research

View full text Add to dashboard Cite

Objectives Medication adherence is emerging as a major public health challenge particularly in patients with depression. The aim of this study was to explore the usefulness of a pharmacist intervention to improve antidepressant medication adherence and disease severity in patients with major depressive disorder. Methods This prospective interventional study was conducted between April 2019 and March 2020 among 101 patients at the Federal Neuro-Psychiatric Hospital, Maiduguri, Nigeria. Consenting patients were randomised into usual care or intervention groups using a computer-generated list. Data were collected at baseline, 3 months and 6 months. Medication adherence and depression severity were assessed using the Medication Adherence Rating Scale and Beck Depression Inventory respectively. Key findings At baseline, both the usual care and intervention groups had low mean scores for medication adherence [5.22 (SD = 1.51) versus 5.46 (SD = 1.46)] and high mean scores for depression severity [24.16 (SD = 13.50) versus 27.07 (SD = 16.12)]. At 6 months, there was a significant difference (P < 0.001) between the mean medication adherence scores of 5.22 (SD = 1.90) and 9.15 (SD = 1.62), in the usual care and intervention groups respectively. A significant difference (P = 0.033) was also observed at 6 months between the mean depression severity scores of the usual care and intervention groups [21.40 (SD = 11.52) and 17.34 (SD = 6.96)]. Medication adherence (P < 0.001, Partial eta squared = 0.279) and depression severity (P < 0.001, Partial eta squared = 0.170) positively changed with time in the presence of the intervention. Conclusions The intervention significantly improved antidepressant medication adherence and disease severity in patients with major depressive disorder.

show abstract

Medication knowledge and beliefs in patients with major depressive disorder at a tertiary health facility in north east Nigeria

Cited by 4 publications

References 0 publications

An exploratory study of outpatient medication knowledge and satisfaction with medication counselling at selected hospital pharmacies in Northwestern Nigeria

An exploratory study of outpatient medication knowledge and satisfaction with medication counselling at selected hospital pharmacies in Northwestern Nigeria

The Role of Clinical Pharmacists as a Collaborative Team for Ambulatory Care in Schizophrenic Patients

Impact of pharmacist intervention on antidepressant medication adherence and disease severity in patients with major depressive disorder in fragile north-east Nigeria

Contact Info

Product

Resources

About